Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets (Unaudited)

v3.26.1
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Millions
Jun. 30, 2026
Dec. 31, 2025
Current assets:    
Cash and cash equivalents $ 370.5 $ 353.1
Receivables, net of allowance for doubtful accounts 115.9 91.9
Inventories 507.7 511.7
Prepaid expenses and other current assets 174.7 188.0
Total current assets 1,168.8 1,144.7
Property, plant, and equipment, at cost, net of accumulated depreciation and amortization 412.5 447.7
Operating lease right-of-use assets 166.7 168.3
Marketing-related intangibles and other intangible assets, net 333.2 315.1
Goodwill 125.9 100.5
Deferred income tax assets 478.6 464.3
Other assets 172.0 145.3
Total assets 2,857.7 2,785.9
Current liabilities:    
Accounts payable 101.3 99.8
Member compensation liabilities 378.0 402.4
Current portion of long-term debt 12.0 20.9
Other current liabilities 482.2 489.8
Total current liabilities 973.5 1,012.9
Long-term debt, net of current portion 2,003.7 1,971.7
Non-current operating lease liabilities 152.1 155.7
Other non-current liabilities 195.3 155.0
Total liabilities 3,324.6 3,295.3
Commitments and contingencies
Shareholders' deficit:    
Common shares, $0.0005 par value; 2.0 billion shares authorized; 104.8 million (2026) and 103.3 million (2025) shares outstanding 0.1 0.1
Paid-in capital in excess of par value 334.8 316.0
Accumulated other comprehensive loss (265.3) (251.5)
Accumulated deficit (544.1) (579.7)
Total Herbalife shareholders' deficit (474.5) (515.1)
Noncontrolling interest 7.6 5.7
Total shareholders' deficit (466.9) (509.4)
Total liabilities and shareholders' deficit $ 2,857.7 $ 2,785.9